Concepedia

AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges

Matthew R. Gardner, Christoph H. Fellinger, Lisa Kattenhorn, Meredith E. Davis-Gardner, Jesse A. Weber, Barnett Alfant, Amber S. Zhou, Neha R. Prasad, Hema R. Kondur, Wendy Newton,

Science Translational Medicine · 2019 · 56 citations · 51 references

DOIFull text

Open access

Concepts

Abstract

and rhesus CD4. Other escape pathways associated with clear fitness costs to the virus. Our data report effective protection of rhesus macaques from SIVmac239.

References

51

Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

Xiping Wei, Julie M. Decker, Hongmei Liu et al. · Antimicrobial Agents and Chemotherapy · 2002 · 1.6K citations · Full text

, , +17

Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1

Emily J. Platt, K Wehrly, Shawn E. Kuhmann et al. · Journal of Virology · 1998 · 1.2K citations · Full text

, , +11

Human Immunodeficiency Virus Type 1<i>env</i>Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Ming Li, Feng Gao, John R. Mascola et al. · Journal of Virology · 2005 · 1.1K citations · Full text

, , +14

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Marina Caskey, Florian Klein, Julio C. C. Lorenzi et al. · Nature · 2015 · 774 citations

, , +12

Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120

Cynthia A. Derdeyn, Julie M. Decker, Jeffrey N. Sfakianos et al. · Journal of Virology · 2000 · 758 citations · Full text

, , +17